[go: up one dir, main page]

AR029278A1 - Metodo para preparar una composicion - Google Patents

Metodo para preparar una composicion

Info

Publication number
AR029278A1
AR029278A1 ARP010103011A ARP010103011A AR029278A1 AR 029278 A1 AR029278 A1 AR 029278A1 AR P010103011 A ARP010103011 A AR P010103011A AR P010103011 A ARP010103011 A AR P010103011A AR 029278 A1 AR029278 A1 AR 029278A1
Authority
AR
Argentina
Prior art keywords
compositions
preparation
relates
dispersion
solution
Prior art date
Application number
ARP010103011A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8169074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR029278(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR029278A1 publication Critical patent/AR029278A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a un método para la preparacion de composiciones, preferentemente composiciones farmacéuticas, en forma de estructuras expandidas, mecánicamente estables, laminares, porosas, espongiforme o en forma de esponja, procedentes de soluciones o dispersiones. Este método comprende los pasos de a) preparacion de una solucion o una dispersion homogénea de un líquido y un compuesto seleccionado del grupo formado por uno o más compuestos farmacéuticamente activos, uno o más excipientes farmacéuticamente adecuados, y mezclas de los mismos, seguido de b) expansion de la solucion o dispersion homogénea sin llegar a la ebullicion. La invencion se refiere también a las composiciones, su posterior procesado y cualquier forma de dosificacion correspondiente obtenible mediante el método de más arriba.
ARP010103011A 2000-06-27 2001-06-25 Metodo para preparar una composicion AR029278A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00113535 2000-06-27

Publications (1)

Publication Number Publication Date
AR029278A1 true AR029278A1 (es) 2003-06-18

Family

ID=8169074

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103011A AR029278A1 (es) 2000-06-27 2001-06-25 Metodo para preparar una composicion

Country Status (37)

Country Link
US (3) US6534087B2 (es)
EP (1) EP1296656B1 (es)
JP (2) JP4149803B2 (es)
KR (1) KR100557845B1 (es)
CN (1) CN1236764C (es)
AR (1) AR029278A1 (es)
AT (1) ATE334662T1 (es)
AU (2) AU8184601A (es)
BR (1) BRPI0112014B1 (es)
CA (1) CA2411153C (es)
CY (1) CY1105714T1 (es)
CZ (1) CZ301813B6 (es)
DE (1) DE60121953T2 (es)
DK (1) DK1296656T3 (es)
EC (1) ECSP024401A (es)
EG (1) EG24141A (es)
ES (1) ES2269441T3 (es)
HR (1) HRP20021009B1 (es)
HU (1) HU229550B1 (es)
IL (2) IL153282A0 (es)
JO (1) JO2247B1 (es)
MA (1) MA26922A1 (es)
ME (1) MEP90608A (es)
MX (1) MXPA02012583A (es)
MY (1) MY129798A (es)
NO (1) NO332181B1 (es)
NZ (1) NZ523024A (es)
PE (1) PE20020101A1 (es)
PL (1) PL203804B1 (es)
PT (1) PT1296656E (es)
RU (1) RU2244542C2 (es)
SI (1) SI1296656T1 (es)
TW (1) TWI278325B (es)
UY (1) UY26799A1 (es)
WO (1) WO2002000201A2 (es)
YU (1) YU96602A (es)
ZA (1) ZA200209649B (es)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
ATE334662T1 (de) * 2000-06-27 2006-08-15 Hoffmann La Roche Herstellungsverfahren von arzneizubereitungen
US20030027786A1 (en) 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
ATE453390T1 (de) 2002-04-26 2010-01-15 Hoffmann La Roche Pharmazeutische zusammensetzung enthaltend einen lipase - inhibitor und glucomannan
KR100517072B1 (ko) * 2002-11-25 2005-09-26 주식회사 태평양 폴리올/고분자 마이크로캡슐 및 이를 이용한 효소 안정화방법
US9174176B2 (en) * 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
EP1699431B1 (en) 2003-12-12 2015-08-19 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
CA2562213A1 (en) * 2004-04-06 2005-11-24 Rpg Life Sciences Limited Mouth dissolvable and meltable, and water dispersable delivery formulation
JP4329816B2 (ja) * 2004-09-15 2009-09-09 萬有製薬株式会社 サンプリング方法、サンプリング装置、ｌｏｇＤ測定方法及びｌｏｇＤ測定システム
EP1837032A4 (en) * 2004-12-31 2009-06-10 Mikhail Yurievich Gotovsky MAGNETIC RESONANCE PREPARATIONS AND DEVICE FOR INDIVIDUALLY SELECTING SUCH PREPARATIONS TO INCREASE THE ACTIVITY OF AN ORGANISM UNDER CURRENT ENVIRONMENTAL CONDITIONS
US20060198856A1 (en) * 2005-03-01 2006-09-07 Keith Whitehead Ibuprofen suspension stabilized with docusate sodium
US20060246141A1 (en) * 2005-04-12 2006-11-02 Elan Pharma International, Limited Nanoparticulate lipase inhibitor formulations
US7984717B2 (en) * 2005-04-29 2011-07-26 Medtronic, Inc. Devices for augmentation of lumen walls
WO2006138431A2 (en) * 2005-06-16 2006-12-28 Eastman Chemical Company Methods and pharmaceutical formulations for increasing bioavailability
WO2006136197A1 (en) 2005-06-21 2006-12-28 V. Mane Fils Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule
WO2006136196A1 (en) * 2005-06-21 2006-12-28 V. Mane Fils Gellan seamless breakable capsule and process for manufacturing thereof
US20070048364A1 (en) * 2005-08-04 2007-03-01 Yingxu Peng Free flowing granules containing carbomer
KR100669497B1 (ko) * 2005-08-17 2007-01-16 보람제약주식회사 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법
AR056499A1 (es) * 2005-09-06 2007-10-10 Serapis Farmaceuticals Ltd Compuestos
EP1951186A4 (en) 2005-10-19 2009-11-04 Menni Menashe Zinger METHODS FOR TREATING HYPERHIDROSIS
WO2007079147A2 (en) 2005-12-28 2007-07-12 Advanced Bionutrition Corporation A delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
FR2895908B1 (fr) * 2006-01-12 2008-03-28 France Etat Procede de fabrication d'une forme pharmaceutique de phosphate d'oseltamivir
JP5255429B2 (ja) 2006-02-20 2013-08-07 中外製薬株式会社 リン酸オセルタミビル含有医薬組成物
EP2002201A2 (en) 2006-03-16 2008-12-17 Duke University Methods, systems, and computer program products for performing real-time quadrature projection based fourier domain optical coherence tomography
CN1820744B (zh) 2006-04-04 2011-01-26 中国人民解放军军事医学科学院毒物药物研究所 磷酸奥司他韦颗粒剂及其制备方法
EP1872777A1 (en) * 2006-06-27 2008-01-02 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising tetrahydrolipstatin
KR100812824B1 (ko) 2006-09-27 2008-03-12 주식회사 제닉 키토산과 폴리에틸렌글리콜을 이용한 생체친화성 저독성필름
JP5285617B2 (ja) 2006-12-18 2013-09-11 アドバンスド バイオニュートリション コーポレーション 生きたプロバイオティクスを含む乾燥食物製品
CN101801359B (zh) * 2007-05-18 2013-11-06 Tti优而美株式会社 确保有效成分经生物界面增加释放的透皮递送设备
KR101439470B1 (ko) * 2007-05-22 2014-09-16 한미사이언스 주식회사 오를리스타트 및 대변 연화제를 포함하는 비만의 예방 또는치료용 조성물
EP2219614A1 (en) * 2007-10-15 2010-08-25 Inventis DDS Pvt Limited Pharmaceutical composition of orlistat
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
GB0900551D0 (en) 2009-01-14 2009-02-11 Horton Richard Ingestible compositions and processes of preparation
EP3266448B1 (en) 2009-03-27 2022-02-16 Intervet International B.V. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
MX2011012586A (es) 2009-05-26 2012-03-26 Advanced Bionutrition Corp Composicion de polvo seco estable que comprende microorganismos biologicamente activos y/o materiales bioactivos y metodos de elaboracion.
AU2010301135A1 (en) * 2009-09-29 2012-04-12 Michael Burnet Novel pesticide formulations
KR100940745B1 (ko) * 2009-10-15 2010-02-04 광동제약 주식회사 오를리스타트 및 아타풀지트 함유 복합제의 코팅펠렛 및 이를 이용한 제제
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
CN102725393B (zh) 2010-01-28 2015-12-02 先进生物营养公司 包含生物活性材料的干燥玻璃质组合物
KR101021030B1 (ko) * 2010-03-25 2011-03-09 엘지이노텍 주식회사 형광체 코팅방법, 발광장치 제조방법 및 코팅된 형광체
DK2557151T3 (en) * 2010-04-07 2017-12-11 Mitsubishi Gas Chemical Co S-adenosyl-L-methionine-containing dry yeast composition with excellent storage stability and process for preparing the same
ES2676656T3 (es) 2010-08-13 2018-07-23 Advanced Bionutrition Corp. Composición estabilizante de almacenamiento en seco para materiales biológicos
JP2013540827A (ja) * 2010-10-29 2013-11-07 ウエスタン ユニバーシティ オブ ヘルス サイエンシズ 三種混合製剤
WO2012125297A1 (en) 2011-03-01 2012-09-20 The Procter & Gamble Company Porous disintegratable solid substrate for personal health care applications
IN2014DN08599A (es) 2012-03-23 2015-05-22 Advanced Bionutrition Corp
CN103222964B (zh) * 2013-01-29 2014-10-08 青岛大学 一种奥利司他口服制剂及其制备方法
GB2524496A (en) * 2014-03-24 2015-09-30 British Airways Plc Dynamic tracking and control of passenger travel progress
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
EP3314007B1 (en) 2015-06-25 2024-01-24 Native Microbials, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
EP3328215B1 (en) 2015-07-29 2021-07-07 Advanced BioNutrition Corp. Stable dry probiotic compositions for special dietary uses
JP6778051B2 (ja) * 2016-08-18 2020-10-28 沢井製薬株式会社 オセルタミビルリン酸塩含有医薬組成物
US11891647B2 (en) 2016-12-28 2024-02-06 Native Microbials, Inc. Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon
WO2018126036A1 (en) 2016-12-28 2018-07-05 Ascus Biosciences, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities with tracer analytics, determination of functional relationships and interactions thereof, and synthesis of microbial ensembles including dosed microbial ensembles and inoculative microbial ensembles
WO2019069108A1 (en) * 2017-10-04 2019-04-11 Debreceni Egyetem SOLID GALENIC FORM, MOLDED, GASTRIC RETENTION AND EXTENDED RELEASE AND METHOD OF PREPARING THE SAME

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
US4489438A (en) * 1982-02-01 1984-12-18 National Data Corporation Audio response system
CA1247547A (en) 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
DE69331839T2 (de) 1992-01-29 2002-12-12 Takeda Chemical Industries, Ltd. Schnellösliche Tablette und ihre Herstellung
US5560921A (en) 1992-06-01 1996-10-01 The Procter & Gamble Company Chewable decongestant compositions
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
NZ262562A (en) * 1993-02-23 1996-04-26 Warner Lambert Co Preparation of solvent free pharmaceutical compositions
DE4317320A1 (de) 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5536264A (en) * 1993-10-22 1996-07-16 The Procter & Gamble Company Absorbent composites comprising a porous macrostructure of absorbent gelling particles and a substrate
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
BR9607098B8 (pt) 1995-02-27 2014-11-18 Gilead Sciences Inc Composto e composição farmacêutica.
HU229200B1 (en) 1995-02-27 2013-09-30 Gilead Sciences Inc Selective inhibitors of viral or bacterial neuraminidase
AU713599B2 (en) * 1995-06-07 1999-12-09 Quadrant Drug Delivery Limited Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
ES2217410T3 (es) * 1996-04-16 2004-11-01 Novartis Consumer Health S.A. Forma de dosificacion oral de rapida desintegracion.
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
BR9713258A (pt) * 1996-10-14 2000-03-28 Hoffmann La Roche Processo para a fabricação de uma preparação pulverosa
US6004996A (en) 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JPH11137208A (ja) 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
US6299906B1 (en) * 1998-04-09 2001-10-09 Hoffmann-La Roche Inc. Process for making submicron particles
DK1105122T3 (da) 1998-08-14 2005-08-08 Hoffmann La Roche Pharmaceutical compositions containing lipase inhibitors
CA2340052C (en) 1998-08-14 2007-05-29 F. Hoffmann-La Roche Ag Pharmaceutical compositions containing lipase inhibitors and chitosan
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
US6342249B1 (en) * 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
GB9900416D0 (en) 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
EP1027886B1 (en) 1999-02-10 2008-07-09 Pfizer Products Inc. Pharmaceutical solid dispersions
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
FR2791569B1 (fr) * 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
ATE334662T1 (de) * 2000-06-27 2006-08-15 Hoffmann La Roche Herstellungsverfahren von arzneizubereitungen

Also Published As

Publication number Publication date
CA2411153A1 (en) 2002-01-03
CA2411153C (en) 2007-01-30
PL203804B1 (pl) 2009-11-30
ATE334662T1 (de) 2006-08-15
ME00672B (me) 2011-12-20
DK1296656T3 (da) 2006-11-27
JO2247B1 (en) 2004-10-07
KR100557845B1 (ko) 2006-03-10
NO20026197D0 (no) 2002-12-23
HU229550B1 (en) 2014-01-28
HRP20021009B1 (hr) 2011-07-31
RU2244542C2 (ru) 2005-01-20
IL153282A0 (en) 2003-07-06
HRP20021009A2 (en) 2004-02-29
SI1296656T1 (sl) 2006-12-31
PT1296656E (pt) 2006-12-29
US20020018812A1 (en) 2002-02-14
JP2007302683A (ja) 2007-11-22
EG24141A (en) 2008-08-06
TWI278325B (en) 2007-04-11
HUP0302060A2 (hu) 2003-09-29
MXPA02012583A (es) 2003-04-10
KR20030023880A (ko) 2003-03-20
NO20026197L (no) 2002-12-23
UY26799A1 (es) 2001-12-28
MEP90608A (bs) 2011-12-20
DE60121953T2 (de) 2007-03-08
BRPI0112014B1 (pt) 2016-09-13
YU96602A (sh) 2005-03-15
ES2269441T3 (es) 2007-04-01
WO2002000201A3 (en) 2002-04-18
ECSP024401A (es) 2003-02-06
BR0112014A (pt) 2003-05-13
EP1296656B1 (en) 2006-08-02
AU8184601A (en) 2002-01-08
JP4149803B2 (ja) 2008-09-17
ZA200209649B (en) 2004-03-10
IL153282A (en) 2008-03-20
JP2004501184A (ja) 2004-01-15
NZ523024A (en) 2004-08-27
DE60121953D1 (de) 2006-09-14
CN1236764C (zh) 2006-01-18
US20030039614A1 (en) 2003-02-27
HK1058314A1 (en) 2004-05-14
CZ301813B6 (cs) 2010-06-30
NO332181B1 (no) 2012-07-16
PE20020101A1 (es) 2002-02-12
PL365803A1 (en) 2005-01-10
MA26922A1 (fr) 2004-12-20
US7074431B2 (en) 2006-07-11
MY129798A (en) 2007-04-30
AU2001281846B2 (en) 2006-04-27
US6534087B2 (en) 2003-03-18
HUP0302060A3 (en) 2006-07-28
CZ2003212A3 (cs) 2003-06-18
WO2002000201A2 (en) 2002-01-03
EP1296656A2 (en) 2003-04-02
CY1105714T1 (el) 2010-12-22
US20060134205A1 (en) 2006-06-22
CN1438880A (zh) 2003-08-27

Similar Documents

Publication Publication Date Title
AR029278A1 (es) Metodo para preparar una composicion
DK1283700T3 (da) Farmaceutiske sustained release-præparater til parenteral administration af biologisk aktive hydrofile forbindelser
AR110270A1 (es) Preparación de complejos sólidos de ciclodextrina para la administración de ingredientes farmacéuticos activos oftálmicos
SV2002000696A (es) Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgesicos pc9985ahxk/bb
AR037642A1 (es) Preformulacion farmaceutica para tabletado, y procedimiento para su preparacion
ES2191977T3 (es) Soluciones y dispersiones en estado solido de farmacos poco solubles en agua.
CL2009001980A1 (es) Combinacion farmaceutica que comprende un derivado de quinolina y uno o mas de otros agentes antimicobacterianos; composicion farmaceutica que la comprende; y uso para el tratamiento de una infeccion por una cepa de mycobacterium resistente a farmacos (divisional de la solicitud 1290-05).
BR0112311A (pt) Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso
CR9292A (es) Comprimidos con dispersion mejorada de la sustancia farmacologica
MX2020010834A (es) Formulacion solida de mezclas insecticidas.
DOP2002000389A (es) Metodo para fabricar una composición farmaceutica de dosis baja que tiene una distribución y potencia del fármaco uniforme
MXPA04004236A (es) Metodo para la formacion de cristales ibuprofeno.
AR034854A1 (es) Compuesto de imidazol condensado, prodroga del mismo, composición farmaceutica y agente para reducir androgenos que lo contienen ,metodo para producirlo, sal diastereomerica de dicho compuesto y metodo para producir un compuesto opticamente activo del compuesto
AR051758A1 (es) Composicion de dispersion solida de pranlukast con biodisponibilidad mejorada y metodo para preparar la dispersion solida
UY27034A1 (es) Derivados de pirimidina
AR089132A1 (es) Composicion microbicida y su proceso de obtencion
AR056512A1 (es) Composicion para la terapia y/o profilaxis de infecciones por virus de la hepatitis b (hbv) y enfermedades mediadas por hbv
CO2023005726A2 (es) Formulación sólida
CL2022000903A1 (es) Formulación de mezclas insecticidas que comprenden disolventes de éter de glicol
PE20180609A1 (es) Composiciones farmaceuticas solidas para el tratamiento del vhc
AR123327A1 (es) Formulaciones de un inhibidor de mcl-1
AR046465A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
AR036256A1 (es) Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento
AR131625A1 (es) Compuestos, composiciones y métodos de uso para tratar el hipoparatiroidismo y la osteoporosis
CO2020002287A2 (es) Composiciones farmacéuticas

Legal Events

Date Code Title Description
FC Refusal